Balchem Corporation (BCPC)
NASDAQ: BCPC · Real-Time Price · USD
164.94
-0.61 (-0.37%)
At close: May 13, 2025, 4:00 PM
164.94
0.00 (0.00%)
After-hours: May 13, 2025, 4:05 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 NaN - NaN
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 NaN - NaN
Human Nutrition and Health
605.97M
Log In
Log In
Log In
Log In
Upgrade
Human Nutrition and Health Growth
6.15%
Log In
Log In
Log In
Log In
Upgrade
Specialty Products
134.41M
Log In
Log In
Log In
Log In
Upgrade
Specialty Products Growth
7.23%
Log In
Log In
Log In
Log In
Upgrade
Animal Nutrition and Health
218.07M
Log In
Log In
Log In
Log In
Upgrade
Animal Nutrition and Health Growth
-4.09%
Log In
Log In
Log In
Log In
Upgrade
Other and Unallocated Business Segment
6.10M
Log In
Log In
Log In
Log In
Upgrade
Other and Unallocated Business Segment Growth
1.41%
Log In
Log In
Log In
Log In
Upgrade
Product Sales
962.88M
Log In
Log In
Log In
Log In
Upgrade
Product Sales Growth
3.84%
Log In
Log In
Log In
Log In
Upgrade
Royalty
1.66M
Log In
Log In
Log In
Log In
Upgrade
Royalty Growth
-25.84%
Log In
Log In
Log In
Log In
Upgrade

EBIT by Product

Fiscal year is January - December.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 NaN - NaN
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 NaN - NaN
Human Nutrition and Health Earnings From Operations
140.67M
Log In
Log In
Log In
Log In
Upgrade
Human Nutrition and Health Earnings From Operations Growth
19.99%
Log In
Log In
Log In
Log In
Upgrade
Specialty Products Earnings From Operations
41.29M
Log In
Log In
Log In
Log In
Upgrade
Specialty Products Earnings From Operations Growth
18.55%
Log In
Log In
Log In
Log In
Upgrade
Animal Nutrition and Health Earnings From Operations
17.19M
Log In
Log In
Log In
Log In
Upgrade
Animal Nutrition and Health Earnings From Operations Growth
-14.64%
Log In
Log In
Log In
Log In
Upgrade
Other and Unallocated Business Segment Earnings From Operations
-6.91M
Log In
Log In
Log In
Log In
Upgrade
Other and Unallocated Business Segment Earnings From Operations Growth
20.12%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 NaN - NaN
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 NaN - NaN
United States
726.94M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
3.14%
Log In
Log In
Log In
Log In
Upgrade
Foreign Countries
237.61M
Log In
Log In
Log In
Log In
Upgrade
Foreign Countries Growth
5.72%
Log In
Log In
Log In
Log In
Upgrade

Other

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 2011 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 2011 - 2019
Human Nutrition and Health Backlog
Log In
Log In
Log In
Log In
Upgrade
Human Nutrition and Health Backlog Growth
Log In
Log In
Log In
Log In
Upgrade
Specialty Products Backlog
Log In
Log In
Log In
Log In
Upgrade
Specialty Products Backlog Growth
Log In
Log In
Log In
Log In
Upgrade
Total Backlog
Log In
Log In
Log In
Log In
Upgrade
Total Backlog Growth
Log In
Log In
Log In
Log In
Upgrade
Animal Nutrition and Health Backlog
Log In
Log In
Log In
Log In
Upgrade
Animal Nutrition and Health Backlog Growth
Log In
Log In
Log In
Log In
Upgrade
Other Business Segment Backlog
Log In
Log In
Log In
Log In
Upgrade
Other Business Segment Backlog Growth
Log In
Log In
Log In
Log In
Upgrade